NZ336225A - Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance - Google Patents

Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance

Info

Publication number
NZ336225A
NZ336225A NZ336225A NZ33622597A NZ336225A NZ 336225 A NZ336225 A NZ 336225A NZ 336225 A NZ336225 A NZ 336225A NZ 33622597 A NZ33622597 A NZ 33622597A NZ 336225 A NZ336225 A NZ 336225A
Authority
NZ
New Zealand
Prior art keywords
preparation
matrix material
active substance
compound containing
auxiliary agent
Prior art date
Application number
NZ336225A
Inventor
Rainer H Muller
Original Assignee
Dds Drug Delivery Service Ges
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996151734 external-priority patent/DE19651734C2/en
Priority claimed from DE1997149897 external-priority patent/DE19749897C1/en
Application filed by Dds Drug Delivery Service Ges filed Critical Dds Drug Delivery Service Ges
Publication of NZ336225A publication Critical patent/NZ336225A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A preparation in the form of a compound containing a matrix material, with an auxiliary substance phase with at least one auxiliary substance and/or an active substance phase with at least one active substance, and a matrix material phase with at least one polymer and/or lipid. The preparation is characterized in that the matrix material phase is incoherent, and the auxiliary and/or active substance phase of the preparation is coherent. The preparation is suited for the production of larger matrix units with controlled release characteristics in accordance with known methods, and in particular for the production of tablets by means of direct compressing.
NZ336225A 1996-12-12 1997-12-10 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance NZ336225A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1996151734 DE19651734C2 (en) 1996-12-12 1996-12-12 Preparation in the form of a polymer-auxiliary compound and / or a polymer-active compound and process for its production and its use for the production of tablets and / or other larger matrix units
DE1997149897 DE19749897C1 (en) 1997-11-12 1997-11-12 Composite especially for tablet production
PCT/EP1997/006893 WO1998025590A2 (en) 1996-12-12 1997-12-10 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance

Publications (1)

Publication Number Publication Date
NZ336225A true NZ336225A (en) 2001-03-30

Family

ID=26032146

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ336225A NZ336225A (en) 1996-12-12 1997-12-10 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance

Country Status (9)

Country Link
EP (1) EP0948321B1 (en)
JP (1) JP2001505899A (en)
AT (1) ATE252378T1 (en)
AU (1) AU732112B2 (en)
BR (1) BR9713702A (en)
CA (1) CA2274832A1 (en)
DE (1) DE59710904D1 (en)
NZ (1) NZ336225A (en)
WO (1) WO1998025590A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
IT1304152B1 (en) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl COMPOSITIONS INCLUDING A PEPTIDE AND POLYLACTIC-GLYCOLIC ACID FOR THE PREPARATION OF SUBCUTANEOUS IMPLANTS HAVING A PROLONGED
GB9921933D0 (en) * 1999-09-17 1999-11-17 Univ Gent Solid shaped articles comprising biologically active substances and a method for their production
JP4261355B2 (en) 2001-10-19 2009-04-30 アイソテクニカ インコーポレイテッド A method for the synthesis of cyclosporine analogues.
DE10315917A1 (en) 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
DE10318897B4 (en) * 2003-04-22 2007-04-26 Levin, Felix, Dr. Stabilized universal test formulation and test kit for protein determination in biological fluids
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
DE102009011805A1 (en) * 2009-03-05 2010-09-09 Almapharm Gmbh & Co. Kg Tableting excipient, useful e.g. to produce food supplement and/or feeding stuff, comprises a condensation core and a fat, which is coated to condensation core, where condensation core and fat are connected together by spray drying
EP3002005A1 (en) 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direct compression excipient based on lactose, cellulose and starch

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (en) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen DIRECT TABLETING AIDS
DE3506276C1 (en) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direct tableting
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
AT403988B (en) * 1994-05-18 1998-07-27 Lannacher Heilmittel SOLID ORAL RETARDED PREPARATION
JPH0977669A (en) * 1995-09-19 1997-03-25 Takeda Chem Ind Ltd Vitamin b group granular product composition and its production

Also Published As

Publication number Publication date
WO1998025590A3 (en) 1998-10-01
EP0948321A2 (en) 1999-10-13
WO1998025590A2 (en) 1998-06-18
DE59710904D1 (en) 2003-11-27
ATE252378T1 (en) 2003-11-15
CA2274832A1 (en) 1998-06-18
AU5755898A (en) 1998-07-03
JP2001505899A (en) 2001-05-08
AU732112B2 (en) 2001-04-12
BR9713702A (en) 2000-10-31
EP0948321B1 (en) 2003-10-22

Similar Documents

Publication Publication Date Title
AU578577B2 (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
AU4709989A (en) Cosmetic or pharmaceutical composition containing microspheres of polymers or of fatty substances filled with at least one active product
CA2309252A1 (en) Process for preparing a detergent tablet
CA2117351A1 (en) Preparation of Tablets of Increased Strength
KR970703133A (en) Process for Producing Active Agent Preparations in the Form of a Solid Solution of the Active Agent in a Polymer Matrix and Active Agent Preparations Obtained Thereby
AU7387294A (en) Reservoir impregnable with an active solution for an iono phoretic transdermic drug delivery device and method of manufacture of such a reservoir
AU6421594A (en) High release solid preparation, preparation and use thereof
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
MXPA97002401A (en) Antiinflammatory agent for external use.
EE03105B1 (en) Formulations containing a pharmacologically ionizable active ingredient and the process for their preparation
AU4464897A (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
NZ336225A (en) Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
MY113919A (en) Layered tablet for the controlled release of active substances
WO1999047543A3 (en) Sustained-release composition including amorphous polymer
JPS5376263A (en) Rotary master cylinder system
AR243537A1 (en) Procedure for preparing rolled cellulosic material.
PT806202E (en) PHARMACEUTICAL COMPOSITION BASED ON LIPOFILAS MATRIXES STABILIZED FOR CONTROLLED LIBERATION OF ACTIVE PRINCIPLES
IL115740A0 (en) A childproof package for active substance patches and a process for the production thereof
AU3706999A (en) Controlled release tablet produced from linear water-insoluble polysaccharides
IL138771A0 (en) A compacted 2,2-dibromo-3-nitrilopropionamide
DE59607949D1 (en) SOLID MEDICINAL FORM WITH POLYMER MATERIAL DISTRIBUTED ACTIVE SUBSTANCE
ES2086026T3 (en) PHARMACEUTICAL ANTINEOPLASTIC EFFECT CONTAINING AS AN ACTIVE SUBSTANCE (2- (N-METHYL-PIPERIDINE) -ETHYL)-OCTADECIL PHOSPHATE AND PROCEDURE FOR ITS PREPARATION.
EP0618232A3 (en) Substance BS-3, an anti-oxidant for fats and an analgesic.
MXPA98008158A (en) Anti-hiv composition containing imidazole derivative.
IL114948A0 (en) A transdermal therapeutic system containing estradiol and a process for the preparation thereof

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)